4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Joinn Laboratories(China)Co.,Ltd. (6127) operates in the Diagnostics & Research industry and is headquartered in Beijing, China with about 2,649 employees. Its market capitalization is roughly CNY 21 billion. In the fiscal year ended 2025-12-31, 6127 reported CNY 1.7B in revenue and CNY 298M in net income.
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 1.7B | CNY 2.0B | CNY 2.4B | CNY 2.3B |
| Gross Profit | CNY 343M | CNY 574M | CNY 1.0B | CNY 1.1B |
| Operating Income (EBIT) | (CNY 42M) | CNY 181M | CNY 634M | CNY 717M |
| Net Income | CNY 298M | CNY 74M | CNY 397M | CNY 1.1B |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 316M | CNY 673M | CNY 381M | CNY 287M | CNY 683M |
| Gross Profit | CNY 65M | CNY 131M | CNY 78M | CNY 82M | CNY 207M |
| Operating Income (EBIT) | (CNY 28M) | CNY 26M | (CNY 2M) | (CNY 15M) | CNY 129M |
| Net Income | CNY 238M | CNY 217M | CNY 20M | CNY 41M | CNY 144M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 22M) | (CNY 120M) | (CNY 214M) | (CNY 138M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | CNY 0M | — | — | CNY 0M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 9.7B | CNY 9.4B | CNY 10.0B | CNY 10.4B | — |
| Total Liabilities | CNY 1.4B | CNY 1.3B | CNY 1.7B | CNY 2.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6127 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms